This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (16)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Hironobu Ihn, MD; Shinichi Sato, MD; Manabu Fujimoto, MD; Kanako Kikuchi, MD, PhD; Kazuhiko Takehara, MD, PhD
Department of Dermatology Faculty of Medicine University of Tokyo 7-3-1 Hongo, Bunkyo-ku Tokyo 113, Japan

Arch Dermatol. 1994;130(10):1327-1328.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Localized scleroderma is generally considered to be limited to the skin and to the subcutaneous tissue beneath the cutaneous lesions. Previous studies have revealed that this disease is accompanied by various immunologic abnormalities. Recently, we discovered that the major antigens of antinuclear antibodies (ANA) detected in localized scleroderma are nuclear histones.¹ In addition, we found that the serum levels of interleukin (IL) 2, IL-4, IL-6, and soluble IL-2 receptor were significantly elevated in patients with localized scleroderma, which suggests that T-cell activation is also involved in its pathogenesis.²

Interleukin 8 is known to be chemotactic for neutrophilic granulocytes and T lymphocytes and is produced by a variety of cell types, such as epithelial cells, fibroblasts (including dermal fibroblasts), and endothelial cells.^3,4

Recently Reitamo et al⁵ reported that IL-8 was detected in 21 (19%) of 108 serum samples of patients with systemic sclerosis (SSc) but not in . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?